// AST – IMS - [DMinute_ROS]

Raymond James Trust Has Decreased Stake in Sanofi (SNY) by $657,888 as Shares Rose; Tristate Cap Hldgs (TSC) Holder Elk Creek Partners Has Trimmed Stake as Market Valuation Declined

Sanofi (NASDAQ:SNY) Logo

Raymond James Trust decreased its stake in Sanofi (SNY) by 50.63% based on its latest 2018Q3 regulatory filing with the SEC. Raymond James Trust sold 14,952 shares as the company’s stock rose 3.59% while stock markets declined. The institutional investor held 14,582 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $651,000, down from 29,534 at the end of the previous reported quarter. Raymond James Trust who had been investing in Sanofi for a number of months, seems to be less bullish one the $105.04 billion market cap company. The stock increased 0.19% or $0.08 during the last trading session, reaching $42.83. About 615,882 shares traded. Sanofi (NYSE:SNY) has risen 2.03% since January 11, 2018 and is uptrending. It has outperformed by 2.03% the S&P500. Some Historical SNY News: 17/04/2018 – SANOFI SAYS CONTAMINE HAS INFORMED COMPANY OF PLANS TO RETIRE; 30/04/2018 – Sanofi: Cemiplimab is Potential Treatment For Squamous Cell Carcinoma; 10/03/2018 – REGENERON, SANOFI CHOLESTEROL DRUG PRALUENT SUCCEEDS IN MAJOR “OUTCOMES” STUDY – DATA; 07/03/2018 – Sanofi: Filing of the 2017 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report; 03/05/2018 – LEXICON PHARMACEUTICALS FILINGS SUBMITTED FOR SOTAGLIFLOZIN; 29/05/2018 – Adaptive Biotechnologies Announces a Collaboration with Sanofi to Use Adaptive’s clonoSEQ® Assay to Measure Minimal Residual Disease in Active and Future lsatuximab Multiple Myeloma Trials; 16/05/2018 – REGENERON, SANOFI: POSITIVE DATA FOR CEMIPLIMAB; 27/04/2018 – Sanofi 1Q Oper Pft EUR1.20B; 19/03/2018 – Fitch Affirms Sanofi at ‘AA-‘; Outlook Negative; 22/05/2018 – FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes

Elk Creek Partners Llc decreased its stake in Tristate Cap Hldgs Inc (TSC) by 7.64% based on its latest 2018Q3 regulatory filing with the SEC. Elk Creek Partners Llc sold 25,752 shares as the company’s stock declined 24.16% with the market. The institutional investor held 311,148 shares of the finance company at the end of 2018Q3, valued at $8.59M, down from 336,900 at the end of the previous reported quarter. Elk Creek Partners Llc who had been investing in Tristate Cap Hldgs Inc for a number of months, seems to be less bullish one the $594.28 million market cap company. The stock decreased 0.10% or $0.02 during the last trading session, reaching $20.59. About 89,379 shares traded. Tristate Capital Holdings, Inc. (NASDAQ:TSC) has declined 4.64% since January 11, 2018 and is downtrending. It has underperformed by 4.64% the S&P500. Some Historical TSC News: 22/05/2018 – TriState Cap Announces Public Offering of Common Stk by Selling Hldrs; 26/03/2018 – TRISTATE HOLDINGS LTD – FY LOSS ATTRIBUTABLE HK$64.2 MLN VS LOSS HK$84.1 MLN; 20/04/2018 – DJ TriState Capital Holdings Inc, Inst Holders, 1Q 2018 (TSC); 04/05/2018 – TriState Cap Closes Acquisition of About $1.06B of Columbia Partners Assets; 26/04/2018 – Emerald Mutual Advisers Trust Buys 1.2% of TriState Capital; 26/03/2018 – TRISTATE HOLDINGS LTD – FY REVENUE HK$1.92 BLN VS HK$2.25 BLN; 23/04/2018 – HK Bourse: Circular From Tristate Holdings Ltd. On Other; 24/05/2018 – TriState Capital Short-Interest Ratio Rises 31% to 16 Days; 13/03/2018 TriState Cap Commences Perpetual Preferred Stk Offering; 14/03/2018 – HK Bourse: Announcement From Tristate Holdings Ltd

Among 13 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 0 Sell and 10 Hold. Therefore 23% are positive. Sanofi-aventis Sa had 31 analyst reports since October 15, 2015 according to SRatingsIntel. HSBC downgraded Sanofi (NASDAQ:SNY) on Friday, April 7 to “Reduce” rating. The firm earned “Hold” rating on Tuesday, September 5 by Cowen & Co. On Thursday, February 8 the stock rating was maintained by Bernstein with “Hold”. The stock of Sanofi (NASDAQ:SNY) earned “Buy” rating by Citigroup on Friday, August 10. The stock of Sanofi (NASDAQ:SNY) earned “Neutral” rating by JP Morgan on Wednesday, April 12. The stock of Sanofi (NASDAQ:SNY) has “Overweight” rating given on Thursday, October 15 by Morgan Stanley. Bernstein downgraded the shares of SNY in report on Monday, November 9 to “Mkt Perform” rating. As per Tuesday, January 23, the company rating was downgraded by Barclays Capital. On Monday, September 10 the stock rating was upgraded by Bank of America to “Buy”. The rating was downgraded by Berenberg to “Hold” on Thursday, May 11.

Analysts await Sanofi (NASDAQ:SNY) to report earnings on February, 6. They expect $0.62 earnings per share, 0.00% or $0.00 from last year’s $0.62 per share. SNY’s profit will be $1.52B for 17.27 P/E if the $0.62 EPS becomes a reality. After $1.07 actual earnings per share reported by Sanofi for the previous quarter, Wall Street now forecasts -42.06% negative EPS growth.

More notable recent Sanofi (NASDAQ:SNY) news were published by: Seekingalpha.com which released: “Sanofi to refocus two global business units – Seeking Alpha” on September 13, 2018, also Streetinsider.com with their article: “Sanofi (SNY) Announces NEJM Published Positive Results of Cablivi for Rare Blood Clotting Disorder – StreetInsider.com” published on January 09, 2019, Seekingalpha.com published: “Sanofi to exclusively supply active ingredient of avanafil to Vivus; shares up 15% after hours – Seeking Alpha” on December 12, 2018. More interesting news about Sanofi (NASDAQ:SNY) were released by: Nasdaq.com and their article: “Is Sanofi (SNY) a Great Stock for Value Investors? – Nasdaq” published on March 19, 2018 as well as Nasdaq.com‘s news article titled: “Mylan (MYL) Gets Favorable Ruling Against Sanofi’s Lantus – Nasdaq” with publication date: December 14, 2018.

Raymond James Trust, which manages about $1.78B US Long portfolio, upped its stake in Ishares (IWD) by 9,558 shares to 83,317 shares, valued at $10.55M in 2018Q3, according to the filing. It also increased its holding in Ishares (IVE) by 3,398 shares in the quarter, for a total of 11,928 shares, and has risen its stake in Ishares (IJH).

More notable recent Tristate Capital Holdings, Inc. (NASDAQ:TSC) news were published by: Nasdaq.com which released: “Analysts Forecast 16% Upside For The Holdings of USMV – Nasdaq” on January 03, 2019, also Nasdaq.com with their article: “Tractor Supply (TSCO) Riding on Initiatives: Time to Buy? – Nasdaq” published on February 20, 2018, Nasdaq.com published: “Tractor Supply (TSCO) Q4 Earnings Top, Issues 2018 View – Nasdaq” on February 01, 2018. More interesting news about Tristate Capital Holdings, Inc. (NASDAQ:TSC) were released by: Nasdaq.com and their article: “Tractor Supply Company Announces Goal to Reduce Carbon Emissions from Facilities by 25 Percent – Nasdaq” published on December 17, 2018 as well as Globenewswire.com‘s news article titled: “Tractor Supply Company Celebrates 80th Anniversary of Operations With Nasdaq Closing Bell Ceremony – GlobeNewswire” with publication date: September 04, 2018.

Elk Creek Partners Llc, which manages about $800.79 million and $1.85 billion US Long portfolio, upped its stake in Advanced Disp Svcs Inc Del by 35,492 shares to 669,497 shares, valued at $18.13M in 2018Q3, according to the filing. It also increased its holding in Maxar Technologies Ltd by 370,024 shares in the quarter, for a total of 761,020 shares, and has risen its stake in Agco Corp (NYSE:AGCO).

Since August 16, 2018, it had 6 insider buys, and 3 insider sales for $338,667 activity. $298,593 worth of Tristate Capital Holdings, Inc. (NASDAQ:TSC) shares were sold by GETZ JAMES F. 1,000 shares were bought by Demas David J, worth $24,579. The insider Seidel Richard B. sold 6,000 shares worth $151,284. The insider Dolan James J. bought $195,800.

Investors sentiment increased to 2.38 in Q3 2018. Its up 0.60, from 1.78 in 2018Q2. It is positive, as 9 investors sold TSC shares while 25 reduced holdings. 28 funds opened positions while 53 raised stakes. 20.79 million shares or 11.11% more from 18.71 million shares in 2018Q2 were reported. Chicago Equity Partners Ltd Liability Corporation reported 116,260 shares stake. Millennium Mngmt Limited Co invested in 184,956 shares or 0.01% of the stock. Clearbridge Invests Lc stated it has 692,622 shares. Moreover, Ameritas has 0% invested in Tristate Capital Holdings, Inc. (NASDAQ:TSC) for 1,979 shares. Maryland-based Brown Advisory Inc has invested 0.06% in Tristate Capital Holdings, Inc. (NASDAQ:TSC). Franklin Resource stated it has 0% of its portfolio in Tristate Capital Holdings, Inc. (NASDAQ:TSC). Janney Management Ltd Liability Corp holds 0% or 10,000 shares in its portfolio. Castine Limited Liability Company invested 2.17% in Tristate Capital Holdings, Inc. (NASDAQ:TSC). Moreover, Mckinley Capital Mngmt Llc Delaware has 0.01% invested in Tristate Capital Holdings, Inc. (NASDAQ:TSC) for 3,681 shares. Bank Of New York Mellon reported 348,591 shares. Stephens Incorporated Ar invested in 217,239 shares. Alps Advisors holds 17,346 shares or 0% of its portfolio. 131,381 were accumulated by D E Shaw & Co. Voya Mngmt Limited Liability invested in 0% or 10,743 shares. Mutual Of America Management Limited Liability owns 160,850 shares.

Among 6 analysts covering TriState Capital Holdings (NASDAQ:TSC), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. TriState Capital Holdings had 27 analyst reports since December 15, 2015 according to SRatingsIntel. The stock of Tristate Capital Holdings, Inc. (NASDAQ:TSC) has “Buy” rating given on Tuesday, December 15 by Maxim Group. The firm earned “Buy” rating on Thursday, July 20 by Maxim Group. The firm has “Buy” rating given on Thursday, October 19 by Maxim Group. Keefe Bruyette & Woods maintained the shares of TSC in report on Monday, June 5 with “Buy” rating. The stock of Tristate Capital Holdings, Inc. (NASDAQ:TSC) earned “Buy” rating by Maxim Group on Friday, July 20. The stock of Tristate Capital Holdings, Inc. (NASDAQ:TSC) earned “Buy” rating by Keefe Bruyette & Woods on Monday, August 21. Stephens maintained Tristate Capital Holdings, Inc. (NASDAQ:TSC) on Friday, January 26 with “Buy” rating. Boenning & Scattergood initiated the shares of TSC in report on Wednesday, October 5 with “Neutral” rating. On Thursday, January 25 the stock rating was maintained by Maxim Group with “Buy”. The firm has “Buy” rating given on Tuesday, December 6 by Maxim Group.

Tristate Capital Holdings, Inc. (NASDAQ:TSC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.